banner
Raltitrexed agent, Mannose-PEG-raltitrexed, Purity ≥95%

Cat. No.: X25-05-YM1831

Raltitrexed agent, Mannose-PEG-raltitrexed, Purity ≥95%

Synonym: Mannose-PEG-raltitrexed; Raltitrexed-PEG-mannose

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
Raltitrexed-PEG-mannose hybrids integrate thymidylate synthase inhibitors conjugated through hydrophilic spacers to carbohydrate units, improving chemotherapeutic delivery to hepatic tissues.
Source
Chemical synthesis
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Mannose-PEG-raltitrexed can be used for its potential to study thymidylate synthase inhibition in colorectal cancer models.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0